Drawing on practical experience, the authors examine key questions and answers about various aspects relating to the enhanced approach for analytical procedure lifecycle management.
Jette Wypych
Advertisement
Jette Wypych is director, Attribute Sciences at Amgen.
Articles by Jette Wypych
Advertisement
Latest Updated Articles
Analytical Procedure Lifecycle Management: Current Status and OpportunitiesPublished: December 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
3
New Targets for Clinical Trials in the European Union
4
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
5
